The global patient monitoring devices market is set for strong, sustained expansion, driven by rising prevalence of chronic diseases, surging demand for remote patient monitoring, and rapid adoption of AI- and IoT-enabled technologies across key geographies.
Key Takeaways
-
The global patient monitoring devices market is projected to grow from USD 51,549.43 million in 2024 to USD 110,387.09 million by 2032, reflecting a CAGR of 10.01% during 2025–2032.
-
North America is expected to dominate the market in 2024, capturing around 43% share, supported by high chronic disease prevalence, strong adoption of advanced healthcare technologies, widespread telehealth infrastructure, and favorable reimbursement policies.
-
Patient Monitoring Devices market growth is underpinned by the rising burden of cardiovascular diseases, diabetes, and respiratory conditions, growing demand for remote and home-based monitoring, rapid technological advancements including AI and IoT, and active product development among key market players.
-
Technological trends include AI-powered diagnostic tools, remote patient monitoring (RPM) expansion, wearable health devices with advanced sensors, integration of 5G connectivity, ultra-wideband (UWB) for real-time location systems, and brain-computer interfaces (BCIs) that enhance clinical decision-making and patient outcomes.
-
By type of devices, blood glucose monitoring systems lead the market; by application, cardiology dominates with approximately 25% share; and hospitals & clinics remain the largest end-user segment, driven by high patient volumes and critical care requirements.
-
Key companies operating in the patient monitoring devices market include Medtronic, GE Healthcare, Philips Healthcare, Abbott Laboratories, Siemens Healthineers, Nihon Kohden Corporation, Masimo Corporation, Omron Healthcare Co., Ltd., Smiths Medical, Hillrom, Welch Allyn, Inc., Natus Medical Incorporated, Mindray Medical International Limited, Nonin Medical, Inc., Spacelabs Healthcare, and others.
Recent Advancements in the Patient Monitoring Devices Landscape
-
Jan 1, 2026: The Centers for Medicare & Medicaid Services (CMS) finalized new CPT codes supporting shorter-duration monitoring and increased reimbursement rates for initial setup ($21.71), device supply 16+ days ($52.11), and the first 20 minutes of monitoring ($51.77).
-
Jul 1, 2025: Medtronic and Philips signed a multi-year strategic partnership to integrate Medtronic’s Nellcor pulse oximetry, Microstream capnography, and BIS brain monitoring consumables into Philips’ patient monitoring platforms.
For more recent advancements in this landscape, visit Patient Monitoring Devices Market Recent Developments
Patient Monitoring Devices Market Overview and Growth Outlook
The patient monitoring devices market is forecast to expand from USD 51,549.43 million in 2024 to USD 110,387.09 million by 2032, growing at a CAGR of 10.01% from 2025 to 2032. This trajectory reflects the escalating global burden of chronic conditions, the accelerating shift toward remote and home-based care, and sustained investment in connected, intelligent monitoring technologies that deliver real-time insights and personalized patient management.
Dive deeper into the Patient Monitoring Devices market trends @ Patient Monitoring Devices Market insights and analysis.
Patient Monitoring Devices Market Regional Insights
North America is anticipated to hold the largest share of approximately 43% of the global market in 2024, driven by high prevalence of chronic diseases such as cardiovascular conditions and diabetes, a well-established telehealth infrastructure, rapid adoption of wearable and AI-enabled monitoring solutions, favorable reimbursement policies, and the strong presence of leading market players.
Furthermore, Europe is expected to remain a key growth engine, supported by advanced healthcare infrastructure, high adoption of digital health technologies, supportive regulatory frameworks, and a growing preference for remote and preventive care. Asia-Pacific is emerging as the fastest-growing regional market, propelled by a large and growing patient population, rising prevalence of chronic diseases, expanding healthcare infrastructure, and government initiatives supporting telemedicine and remote patient monitoring across countries including China, India, and Japan.
For in-depth regional analysis, visit Patient Monitoring Devices Market Regional analysis and market share
Patient Monitoring Devices Market Segmentation
-
By Type of Devices: Neuromonitoring Devices, Cardiac Monitoring Devices, Respiratory Monitoring Devices, Hemodynamic Monitoring Devices, Blood Glucose Monitoring Systems, Multi-parameter Monitoring Devices, Others
-
By Application: Cardiology, Neurology, Respiratory, Others
-
By End-User: Hospitals & Clinics, Ambulatory Surgical Centers, Home Care Settings, Others
-
By Geography: North America, Europe, Asia-Pacific, Rest of the World
Patient Monitoring Devices Market Competitive Landscape
The competitive landscape is partially consolidated, with major multinational players dominating hospital-based monitoring segments, while specialized firms and innovative startups drive growth in remote monitoring, continuous glucose monitoring, and neuromonitoring niches.
Key global players include Medtronic, GE Healthcare, Philips Healthcare, Abbott Laboratories, Siemens Healthineers, Nihon Kohden Corporation, Masimo Corporation, Omron Healthcare Co., Ltd., Smiths Medical, Hillrom, Welch Allyn, Inc., Natus Medical Incorporated, Mindray Medical International Limited, Nonin Medical, Inc., Spacelabs Healthcare, and others.
Which company is expected to dominate the Patient Monitoring Devices market? Know @ Patient Monitoring Devices Competitive landscape.
Key Features of DelveInsight’s Patient Monitoring Devices Market Report
-
Detailed market sizing and forecasts from 2022 to 2032 at global and regional levels, including revenue projections and CAGR analysis.
-
Granular assessment of market contribution by major regions such as North America, Europe, Asia-Pacific, and Rest of the World.
-
Coverage of key device categories, including neuromonitoring devices, cardiac monitoring devices, respiratory monitoring devices, hemodynamic monitoring devices, blood glucose monitoring systems, and multi-parameter monitoring systems.
-
Evaluation of usage across care settings, including hospitals & clinics, ambulatory surgical centers, and home care settings where patient monitoring is routinely performed.
-
Detailed discussion on why North America is expected to dominate, including drivers such as high chronic disease prevalence, technological adoption, robust telehealth infrastructure, and reimbursement support.
-
Insight into Europe’s and Asia-Pacific’s growth drivers, including digital health adoption, government-backed telemedicine initiatives, and expanding manufacturer investments in high-growth emerging markets.
-
Systematic coverage of demand drivers such as rising global burden of cardiovascular diseases and diabetes, increasing adoption of remote patient monitoring, and growing preference for home-based and ambulatory care solutions.
-
Identification of evolving opportunities around AI and machine learning integration, 5G-enabled monitoring platforms, wearable health devices with advanced sensors, and brain-computer interface technologies that are redefining the standard of patient care.
-
Profiles and strategic analysis of major companies in the Patient Monitoring Devices landscape.
-
Assessment of market concentration, technology adoption trends, recent regulatory milestones, startup funding activity, U.S. tariff impact analysis, and strategic levers for market entry or expansion.
Request Custom Analysis or Speak to Our Analyst @ Patient Monitoring Devices Market Report
Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Arpit Anand
Email: Send Email
Phone: +14699457679
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: Nevada
Country: United States
Website: https://www.delveinsight.com/consulting/due-diligence-services